Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Increasing Risk of Eye Infections from Contact Lens Use to Surge Ophthalmology…
Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19335 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19335 The use of contact lenses has increased in recent times to enhance appearance and eyesight. This is generating the risk of ocular infections among the population. Around 1 million eye infections occur inthe...
PR Newswire
27/03/2024
Zymeworks Announces Participation in Upcoming Investor Conferences
23 rdAnnual Needham Virtual Healthcare Conference: Zymeworks' management will participate in virtual one-on-one meetings and present on April 11 that 11:45 am Eastern Time (ET).Canaccord Genuity Horizons in Oncology Virtual Conference: Zymeworks' management will participate in virtual one-on-one meetings and a panel discussion on April 15 that 3:00 pm ET.Stifel Virtual Targeted Oncology Days Conference: Zymeworks' management will participate in virtual one-on-one meetings and...
Nasdaq GlobeNewswire
27/03/2024
PLGA Market worth $321 Million by 2030 - Exclusive Report by MarketsandMarkets™
Browse in-depth TOC on "PLGA Market". Browse in-depth TOC on "PLGA Market". 180 – Tables 110 – Figures 260 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143024577 "Injection molding is projected to be the fastest growing processibility type of PLGA, in terms of value, during the forecast period." Injection molding stands as a pivotal processibility type for PLGA (poly (lactic-co-glycolic acid)), offering businesses in...
PR Newswire
27/03/2024
Data from Brainomix's Collaboration with AstraZeneca Shows its AI-Powered e-Lung…
The study was an analysis of AstraZeneca's Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix's e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung. The study was an analysis of AstraZeneca's Phase 2 52-Week clinical trial of tralokinumab in patients with...
PR Newswire
27/03/2024
PROTEONIC UNVEILS EARLY ACCESS PROGRAM, ELEVATING VIRAL VECTOR TITERS WITH…
With the official launch onMarch 20, 2024, ProteoNic extends a warm invitation to CDMOs, biotechs, and biopharmaceutical companies to experience firsthand the transformative potential of LV-2G UNic ®. By seamlessly integrating this cutting-edge vector technology into existing systems, participants can achieve remarkable enhancements in titers, paving the way for increased viral vector production capacity and substantial improvements in manufacturing cost efficiency. Frank Pieper...
PR Newswire
27/03/2024
Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop®…
An estimated 27% of the adult population in the U.S. struggle with GERD1 and 40% of GERD patients don't respond to PPIs, the most common medication to treat the disease.2 This leaves tens of millions of patients with limited options to treat the relentless, painful symptoms of GERD. Even worse, in the U.S. and EU, around 48,000 people die annually from esophageal adenocarcinoma, with strong indications in the literature to be caused by acid reflux. An estimated 27% of the adult population in the…
PR Newswire
27/03/2024
Convening of the ordinary general meeting of shareholders of April 26, 2024
Convening of the Ordinary General Meeting of shareholders of 26 april 2024The shareholders are invited to attend the ordinary general meeting, which will take place on Friday 26th of April 2024 at 11:00AM, at the registered seat in 1070 Brussels (Anderlecht), Allée de la Recherche 60.The board of directors has decided not to organize a remote general meeting in accordance with article 7:137, §1 of the Companies and Associations Code.Agenda of the ordinary general meeting of 26 april 2024...
Nasdaq GlobeNewswire
27/03/2024
Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted…
Pratteln, Switzerland, March 27, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that the China National Medical Products Administration (NMPA) has accepted for priority review the new drug application (NDA) for vamorolone in Duchenne muscular dystrophy (DMD) which was submitted by Sperogenix Therapeutics, Santhera's specialized rare disease partner for China. The Center for Drug Evaluation (CDE) of the Chinese drug authority NMPA accepted the filing and granted priority review for...
Nasdaq GlobeNewswire
27/03/2024
TUMI DEBUTS WOMEN'S ASRA COLLECTION WITH CAMPAIGN STARRING NEW GLOBAL BRAND…
The Asra collection will seamlessly transition from day to night, with feminine designs and elevated accents that merge functionality with style. The collection includes three different sizes and four compelling colors – TUMI's core Matte Black and three seasonal colors Moonlight, Cameo Rose, and Purple Sunset, the latter a vibrant colorway inspired by the beautiful landscapes of Sentosa island in Singapore. The Asra collection will seamlessly transition from day to night, with feminine…
PR Newswire
27/03/2024
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer…
With broad application in radio-guided surgery across multiple procedures and major cancer types, SENSEI® is currently indicated for use during SLN biopsy in prostate, endometrial and cervical cancers. As part of an investigator-initiated clinical trial, SENSEI® was used by Dr. Lluís Cecchini with the da Vinci Xi surgical robotic platform in a patient scheduled for radical cystectomy and Bricker urinary diversion with SLN biopsy. With broad application in radio-guided surgery across multiple...
PR Newswire
26/03/2024
Oclean Introduces the Future of Oral Care in Europe with the New X Ultra
Discover the Futuristic Innovations of Visible Brushing and AI Voice Guidance Imagine a toothbrush that tells you how to better brush your teeth in real time. Now this is possible with Oclean X Ultra and its real-time AI voice guide powered by AI system and oral bone conduction technology. These features provide users with personalised guidance, improving brushing techniques and habits. The Smart Touchscreen further provides a Visible Brushing experience, offering 8 brushing area...
PR Newswire
26/03/2024
Transactions in Zealand Pharma shares and/or related securities by persons…
Company announcement – No. 20 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, March 26, 2024–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or...
Nasdaq GlobeNewswire
26/03/2024
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of…
Company announcement – No. 19 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 26, 2024–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 32,808 divided into 32,808 new shares with a nominal value of DKK 1...
Nasdaq GlobeNewswire
26/03/2024
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to…
Mechelen, Belgium; 26 March 2024, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announcedthat during its meeting of 26 March 2024, the Board of Directors appointed Mr. Dickinson as Non-Executive Non-Independent Director by way of cooptation.Andrew Dickinson is Gilead's Chief Financial Officer (CFO) and replaces Daniel O'Day, Gilead's Chairman and Chief Executive Officer (CEO), who was a member of the Galapagos Board of Directors from 22 October 2019 to 26 March 2024.Mr...
Nasdaq GlobeNewswire
26/03/2024
2023 Shareholders General Meeting
Press release Ecully, March 26, 2024 – 8.00 p.m. Minutes of the General Meeting of March 25, 2024 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice onMonday, March 25, 2024 at 4:00 p.m.at the company's registered office, 7 allée Moulin Berger in Ecully (69).Taking into account the representation of defaulting shareholders by SELARL TULIER POLGE ALIREZAI, asad hocagent appointed by Order of the President of...
Nasdaq GlobeNewswire
26/03/2024
Fogging Machines Market Grows in Response to Escalating Demand for Effective…
Browse in-depth TOC on the Fogging Machines Market Browse in-depth TOC on the Fogging Machines Market 340 – Pages 104 - Tables82- Figures Fogging Machines Market Report Scope The APAC Fogging Machine Market to Reach$3.74 Billionby 2029 India,China, andJapanmainly drive the market growth of APAC. The rising demand for professional floor cleaning and disinfection equipment in these countries is supported by their strong economic growth,...
PR Newswire
26/03/2024
Information on the Total Number of Voting Rights (Denominator) following…
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential market opportunities of USD 3-6 billion...
Nasdaq GlobeNewswire
26/03/2024
Keymed Biosciences Announces 2023 Annual Results and Business Updates
Pipeline Highlights Pipeline Highlights The progress of core pipeline products: Stapokibart (CM310) (IL-4Rα antibody) CMG901/AZD0901 (Claudin 18.2 antibody conjugated) CM313 (CD38 antibody) CM326 (TSLP antibody) Progress of other pipeline products: CM355/ICP-B02 (CD20xCD3 bispecific antibody) CM336 (BCMAxCD3 bispecific antibody) CM350 (GPC3xCD3 bispecific antibody) CM338 (MASP-2 antibody) CM369/ICP-B05 (CCR8 antibody) CM383 (Aβ...
PR Newswire
26/03/2024
Market Leaders Strategize to Meet Escalating Demand in Research Antibodies &…
Browse In-depth TOC on the Research Antibodies & Reagents Market Browse In-depth TOC on the Research Antibodies & Reagents Market 447 – Pages 187 - Tables 146 - Figures Research Antibodies & Reagents Market Report Scope • Rise in Proteomics and Genomics Research The research antibodies and reagents market is vital to the global life sciences and biotechnology sectors. It serves as an essential tool for researchers and scientists across disciplines...
PR Newswire
26/03/2024
Roche receives FDA approval for the first molecular test to screen for malaria…
The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malariaMalaria is a serious and potentially fatal parasitic infection most commonly transmitted by mosquitoes that can also be spread through blood transfusionRoche is dedicated to saving patients' lives through diagnostic solutions that aid in the protection of the global blood supply from infectious diseasesBasel, 26 March 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today...
Nasdaq GlobeNewswire
26/03/2024
Annual General Meeting of AB SKF
The Board members and the CEO were discharged from liability for their administration of the company for the financial year 2023. The Board members and the CEO were discharged from liability for their administration of the company for the financial year 2023. Hans Stråberg, Hock Goh,Geert Follens, Håkan Buskhe,Susanna Schneeberger,Rickard Gustafson,Beth Ferreira,Therese Friberg,Richard Nilssonand Niko Pakalén were re-elected as Board members. Hans Stråberg was elected...
PR Newswire
26/03/2024
Norgine receives positive CHMP opinion recommending approval of NPJ5008…
The European Commission (EC) will now review the CHMP's recommendation. If approved, the centralized marketing authorization would be valid in all 27 EU member states, as well as inIceland,Liechtenstein, andNorwayand would be the first new treatment inEuropefor malignant hyperthermia in over forty years. Submissions to the UK MHRA and Swiss Medic are ongoing. DrDavid Gillen , Chief Medical Officer of Norgine, added: "We are delighted to have received a positive CHMP...
PR Newswire
26/03/2024
Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host…
EPLive is an intensive, two-day educational meeting for physicians, advanced practice registered nurses and allied health professionals who have an interest in treating complex cardiac arrhythmias, a condition in which the heart beats with an irregular or abnormal rhythm. Live cases, which are broadcast with expert commentary from the state-of-the-art Electrophysiology Center at St. David's Medical Center, will serve as the primary teaching tool. EPLive is an intensive, two-day educational...
PR Newswire
26/03/2024
Global Medical Metal Tubing Market to Reach $1,161.9 Million, by 2030 at 7.4%…
Market Trends: Market Trends: There are two key trends shaping the Medical Metal Tubing Market. The first trend is the increasing adoption of nitinol-based medical tubing. Nitinol, a nickel-titanium alloy, offers unique shape memory and superelastic properties, making it suitable for various medical applications. Nitinol tubing is widely used in the manufacturing of stents, catheters, guidewires, and other medical devices, as it provides flexibility, kink resistance, and excellent...
PR Newswire
26/03/2024
Altri Comunicati
